NICOLE CHHATRIWALLA: Open Payments
NPI 1043660392 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 29 payments from 10 companies in 2025. Trend: 2023 $877 · 2024 $1,648 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $135 |
| E.R. Squibb & Sons, L.L.C. | 6 | $108 |
| Novo Nordisk Inc | 4 | $82 |
| Amgen Inc. | 5 | $74 |
| Boston Scientific Corporation | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| PFIZER INC. | 3 | $52 |
| Acist Medical Systems, Inc. | 1 | $31 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: ELIQUIS, Wegovy, CAMZYOS, REPATHA, WATCHMAN FLX, LEQVIO, CVI Systems, LifeVest.
Industry payments across KS — which companies pay providers there.
